secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2022-04-04T23:59:59+00:00
Accession:  0001193125-22-095085
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.05
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences board adopts new Code of Business Conduct and Ethics
----------------------------------------------------------------------

- Board approved new Code of Business Conduct and Ethics on March 30, 2022.
- New code replaces prior code in its entirety; no explicit or implicit waivers granted.
- Code applies to all employees, officers, directors of Solid Biosciences and its subsidiaries.
- Full text posted at https://investors.solidbio.com/governance/governance-documents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522095085/0001193125-22-095085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522095085/d272083d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-095085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer